Generic warfarin: a cost-effective alternative to brand-name drug or a clinical wild card? [electronic resource]
Producer: 19980310Description: 261-3 p. digitalISSN:- 0012-3692
- Aged
- Anticoagulants -- chemistry
- Atrial Fibrillation -- complications
- Biological Availability
- Cerebrovascular Disorders -- prevention & control
- Chemistry, Pharmaceutical
- Clinical Trials as Topic
- Cost-Benefit Analysis
- Drug Costs
- Drugs, Generic -- economics
- Humans
- Patient Selection
- Therapeutic Equivalency
- Thromboembolism -- prevention & control
- Warfarin -- chemistry
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.